Moderna shares pop 7% after Cowen upgrades stock, saying it 'will be a leader' in RSV vaccines

Generating your feed, please be patient ...

Moderna shares pop 7% after Cowen upgrades stock, saying it 'will be a leader' in RSV vaccines | Zootzle